Rivaroxaban Tablets 10 mg, 15 mg, 20 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 15 mg, 20 mg
Reference Brands: Xarelto(US & EU), Rivabloc (India), Rivax (LATAM)
Category: Blood Disorder
Rivaroxaban inhibits factor Xa, reducing thrombin generation and clot formation. It effectively prevents strokes, deep vein thrombosis, and pulmonary embolism. Benefits include oral administration, predictable effects, no routine blood monitoring needed, and rapid onset, making it a convenient and effective anticoagulant for both prophylaxis and treatment of thromboembolic disorders.
Product Description:
Rivaroxaban is a widely used oral anticoagulant regulated by the FDA in the US and the EMA in the EU. It requires a robust dossier demonstrating safety, efficacy, and manufacturing quality for approval. In the US, it is approved as Xarelto, with a focus on stroke prevention, DVT, and PE treatment. In the EU, similar approvals are granted through centralized procedures, ensuring compliance with regional standards. For expert guidance on dossier preparation, regulatory pathways, and market entry strategies, visit PharmaTradz. Ensuring regulatory compliance is critical for successful registration and commercialization of rivaroxaban products globally.
Rivaroxaban Tablets — third party manufacturing & bulk supply
Rivaroxaban Tablets 10 mg, 15 mg, 20 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Rivaroxaban Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Rivaroxaban Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Rivaroxaban Tablets →Frequently Asked Questions
Rivaroxaban is used to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used for the prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery.
Rivaroxaban is a direct factor Xa inhibitor that selectively blocks factor Xa in the coagulation cascade, reducing thrombin generation and preventing clot formation.
The primary trade name is Xarelto, along with various generic brands available worldwide.
Rivaroxaban is manufactured by Bayer and is also produced by multiple pharmaceutical companies globally as a generic medicine.
The generic name is Rivaroxaban.
Brand names include Xarelto and other regional generics.
Rivaroxaban is manufactured in the USA, Europe, India, and other regions by multiple pharmaceutical companies under approved regulatory standards.
Related Products
Acenocoumarol Tablet
Strength:
1 mg, 2 mg, 4 mg
Form: Tablet
Reference Brands: Sintrom(EU)
View DetailsApixaban Tablet
Strength:
2.5 mg, 5 mg
Form: Tablet
Reference Brands: Eliquis(US /EU/ India)
View DetailsWarfarin Tablets
Strength:
1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg, 10 mg
Form: Oral Tablets
Reference Brands: Coumadin(US), Jantoven (USA), Aciwar (India)
View DetailsDabigatran Capsule
Strength:
75 mg, 110 mg, and 150 mg
Form: Capsules
Reference Brands: Pradaxa(EU & US)
View DetailsCrizanlizumab Infusion
Strength:
10 mg/mL
Form: Infusion Solution
Reference Brands: Adakveo(US)
View DetailsDeferoxamine Injection
Strength:
500 mg/mL
Form: Injection
Reference Brands: Desferal(US)
View DetailsDeferiprone Tablets
Strength:
250 mg, 500 mg
Form: Tablet
Reference Brands: Ferriprox(US)
View DetailsQuick Response Guaranteed | Verified Suppliers